Benzinga's Top Downgrades

Analysts at Canaccord Genuity downgraded NPS Pharmaceuticals, Inc. NPSP from Buy to Hold. The price target for NPS Pharmaceuticals is set to $42. NPS Pharmaceuticals' shares closed at $41.91 on Friday. Analysts at Goldman Sachs downgraded Schlumberger Limited SLB from Buy to Neutral. The price target for Schlumberger has been lowered from $90 to $76. Schlumberger's shares closed at $81.22 on Friday. Analysts at Atlantic Equities downgraded Google Inc. GOOG from Overweight to Neutral. Google's shares closed at $496.17 on Friday. Analysts at JMP Securities downgraded Morgan Stanley MS from Market Outperform to Market Perform and removed the price target of $38.00. Morgan Stanley's shares closed at $36.88 on Friday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: DowngradesAnalyst RatingsTop Downgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!